398 related articles for article (PubMed ID: 27053671)
1. Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.
Brossier F; Guindo D; Pham A; Reibel F; Sougakoff W; Veziris N; Aubry A
J Clin Microbiol; 2016 Jun; 54(6):1573-1580. PubMed ID: 27053671
[TBL] [Abstract][Full Text] [Related]
2. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.
Tagliani E; Cabibbe AM; Miotto P; Borroni E; Toro JC; Mansjö M; Hoffner S; Hillemann D; Zalutskaya A; Skrahina A; Cirillo DM
J Clin Microbiol; 2015 Sep; 53(9):2961-9. PubMed ID: 26179309
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the GenoType MTBDR
Gardee Y; Dreyer AW; Koornhof HJ; Omar SV; da Silva P; Bhyat Z; Ismail NA
J Clin Microbiol; 2017 Mar; 55(3):791-800. PubMed ID: 27974543
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
[TBL] [Abstract][Full Text] [Related]
7. Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania.
Bang D; Andersen SR; Vasiliauskienė E; Rasmussen EM
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):377-381. PubMed ID: 27641092
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol with Genotype MTBDRsl Assay: a Meta-Analysis.
Mao X; Ke Z; Shi X; Liu S; Tang B; Wang J; Huang H
Ann Clin Lab Sci; 2015; 45(5):533-44. PubMed ID: 26586705
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates.
Kardan-Yamchi J; Amini S; Hamzelou G; Rahimi Foroushani A; Ghodousi A; Cirillo DM; Feizabadi MM
Arch Microbiol; 2021 Sep; 203(7):3989-3996. PubMed ID: 34032874
[TBL] [Abstract][Full Text] [Related]
10. Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.
Zhang Z; Liu M; Wang Y; Pang Y; Kam KM; Zhao Y
Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):1959-66. PubMed ID: 24906439
[TBL] [Abstract][Full Text] [Related]
11. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
[TBL] [Abstract][Full Text] [Related]
12. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis.
Huang WL; Chi TL; Wu MH; Jou R
J Clin Microbiol; 2011 Jul; 49(7):2502-8. PubMed ID: 21562102
[TBL] [Abstract][Full Text] [Related]
13. GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory.
Pinhata JMW; Brandao AP; Gallo JF; Oliveira RS; Ferrazoli L
Diagn Microbiol Infect Dis; 2023 Feb; 105(2):115856. PubMed ID: 36446302
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of GenoType MTBDRsl for testing resistance of Mycobacterium tuberculosis isolates to fluoroquinlone, aminoglycoside, and ethambutol].
Chikamatsu K; Aono A; Yamada H; Mitarai S
Kekkaku; 2012 Oct; 87(10):641-7. PubMed ID: 23214120
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.
Georghiou SB; Magana M; Garfein RS; Catanzaro DG; Catanzaro A; Rodwell TC
PLoS One; 2012; 7(3):e33275. PubMed ID: 22479378
[TBL] [Abstract][Full Text] [Related]
16. Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
Gao Y; Zhang Z; Deng J; Mansjö M; Ning Z; Li Y; Li X; Hu Y; Hoffner S; Xu B
J Infect; 2018 Oct; 77(4):328-334. PubMed ID: 29969597
[TBL] [Abstract][Full Text] [Related]
17. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide testing by MTBDRsl in Armenia.
Margaryan H; Farnia P; Hayrapetyan A; Mirzoyan A
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S159-S160. PubMed ID: 28043525
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
Ogari CO; Nyamache AK; Nonoh J; Amukoye E
BMC Infect Dis; 2019 Mar; 19(1):279. PubMed ID: 30909867
[TBL] [Abstract][Full Text] [Related]
20. Pyrosequencing for rapid detection of Mycobacterium tuberculosis second-line drugs and ethambutol resistance.
Lacoma A; Molina-Moya B; Prat C; Pimkina E; Diaz J; Dudnyk A; García-Sierra N; Haba L; Maldonado J; Samper S; Ruiz-Manzano J; Ausina V; Dominguez J
Diagn Microbiol Infect Dis; 2015 Nov; 83(3):263-9. PubMed ID: 26256417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
